[1]韩彬,孟艳,杭菁.超声引导下微波消融联合125I粒子植入治疗结直肠肝转移癌的效果 [J].介入放射学杂志,2024,33(12):1325-1329.
　HAN Bin,MENG Yan,HANG Jing..The efficacy of ultrasound-guided microwave ablation combined with 125I seed implantation for the treatment of liver metastases from colorectal cancer[J].journal interventional radiology,2024,33(12):1325-1329.

点击复制

超声引导下微波消融联合125I粒子植入治疗结直肠肝转移癌的效果
()

PDF下载中关闭

• 
• 
• 

分享到：

参考文献/References:

［1］于军，任东栋，任春玲，等.对比PET/MRI与PET/CT检出肝转移癌效能［J］.中国医学影像技术，2021：1609-1613.
［2］Meng Y，Jiang B，Yan K，et al.Evaluation of the safety and efficacy of ultrasound-guided percutaneous radiofrequency ablation for hepatocellular carcinoma and liver metastases adjacent to the gallbladder［J］.Int J Hyperthermia，2023，40：2182748.
［3］高福磊，黄祥忠，王浩，等.125I粒子植入治疗寡转移非小细胞肺癌106例分析［J］.介入放射学杂志，2021，30：1250-1255.
［4］Zhai Y，Shao Y，Li Q.Case report：a case of radioactive iodine-refractory thyroid cancer accompanying cervical lymph node metastasis treated with US-guided RFA combined with 125I seed implantation［J］.Front Oncol，2022，12：987484.
［5］中国抗癌协会肝癌专业委员会.原发性肝癌的临床诊断与分期标准［J］.中华肝脏病杂志，2001，9：324.
［6］邵梦扬.实体瘤疗效综合评定标准［A］.全国第三届中医肿瘤学术年会［C］.北京：中国中医药学会，2001：64-66.
［7］Pang C，Ma Y，Shi W，et al.Prognostic significance of serum tumor markers in various pathologic subtypes of gastric cancer［J］.J Gastrointest Surg，2024，28：694-702.
［8］Qin S，Wang J，Yuan H，et al.Liver function indicators and risk of hepatocellular carcinoma：a bidirectional mendelian randomization study［J］.Front Genet，2023，14：1260352.
［9］Zhang J，Sun Z，Yuan H，et al.Alternatives to the Kaplan-Meier estimator of progression-free survival［J］.Int J Biostat，2020，17：99-115.
［10］Hoshino T，Naganuma A，Furusawa A，et al.A case of conversion hepatectomy for huge hepatocellular carcinoma with adrenal metastasis and vascular invasion after atezolizumab-bevacizumab treatment［J］.Clin J Gastroenterol，2022，15：776-783.
［11］王文轩，张福洲，徐晓雪，等.对比TACE联合射频消融与联合微波消融治疗原发性肝细胞癌效果：Meta分析［J］.中国介入影像与治疗学，2023，20：467-472.
［12］Tucci C，Trujillo M，Berjano E，et al.Mathematical modeling of microwave liver ablation with a variable-porosity medium approach［J］.Comput Methods Programs Biomed，2022：106569.
［13］Song M，Zhou X，Hou R，et al.CT-guided radioactive 125I seeds brachytherapy for lung oligometastases from colorectal cancer：initial results［J］.BMC Cancer，2024，24：265.
［14］Xiao W，Huang H，ZhengP，et al.The CXCL10/CXCR3 pathway contributes to the synergy of thermal ablation and PD-1 blockade therapy against tumors［J］.Cancers （Basel），2023，15：1427.
［15］Kang TW，Lim HK，Cha DI.Percutaneous ablation for perivascular hepatocellular carcinoma：Refining the current status based on emerging evidence and future perspectives［J］.World J Gastroenterol，2018，24：5331-5337.
［16］Zhang H，WangJ，Li W，et al.Microwave ablation combined with 125I seed implantation for treatment of residual lesions of liver cancer after TACE［J］.J Cancer Res Ther，2022，18：1392-1396.
［17］Müller M，Reguzova A，Loffler MW，et al.Orf virus-based vectors preferentially target professional antigen-presenting cells，activate the sting pathway and induce strong antigen-specific t cell responses［J］.Front Immunol，2022，13：873351.
［18］Tan L，Chen Z，Wang W，et al.Analysis of the influencing factors of tumor volume，body immunity，and poor prognosis after 125I particle therapy for differentiated thyroid cancer［J］.Mediators Inflamm，2023，2023：8130422.
［19］Zhu HQ，Wang DY，Xu LS，et al.Diagnostic value of an enhanced MRI combined with serum CEA，CA19-9，CA125 and CA72-4 in the liver metastasis of colorectal cancer［J］.World J Surg Oncol，2022，20：401.
［20］Vaidya M，Sugaya K.DNA associated with circulating exosomes as a biomarker for glioma［J］.Genes （Basel），2020，11：1276.
［21］Lin J，Rao D，Zhang M，et al.Metabolic reprogramming in the tumor microenvironment of liver cancer［J］.J Hematol Oncol，2024，17：6.
［22］Zhu W，Zhang X，Yu M，et al.Radiation-induced liver injury and hepatocyte senescence［J］.Cell Death Discov，2021，7：244.